Atom Investors LP Innoviva, Inc. Transaction History

Atom Investors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $1.54 Million - $1.87 Million	-134,226 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $5.63 Million - $6.55 Million	-508,658 Reduced 79.12%	134,226 $1.6 Million
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $1.36 Million - $1.82 Million	-146,194 Reduced 18.53%	642,884 $7.97 Million
Q3 2020 Nov 13, 2020	BUY	$10.33 - $14.49 $6.47 Million - $9.08 Million	626,667 Added 385.85%	789,078 $8.25 Million
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $8.61 Million - $11.4 Million	-749,367 Reduced 82.19%	162,411 $2.27 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $1.28 Million - $2.41 Million	157,943 Added 20.95%	911,778 $10.7 Million
Q4 2019 Feb 13, 2020	SELL	$10.28 - $14.38 $1.04 Million - $1.46 Million	-101,621 Reduced 11.88%	753,835 $10.7 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $5.83 Million - $8.45 Million	580,464 Added 211.08%	855,456 $9.02 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $1.32 Million - $1.5 Million	100,506 Added 57.6%	274,992 $4 Million
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $2.39 Million - $3.5 Million	174,486 New	174,486 $2.45 Million

243

77.7M

52.8K

800

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.